Greenbrook TMS, a provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, entered into a purchase agreement to acquire Achieve TMS East and Achieve TMS Central.
The company also entered into an agreement to sell 1.3 million common shares on a bought deal basis at a price of $7.75 per share. Read more.
